Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.
⚠ Use acetic acid — not bacteriostatic water
PEG-IGF-1 is insoluble or unstable in standard BAC water. Manufacturer protocols require reconstitution in dilute acetic acid (0.1%) — or, for IGF-1 variants, 50 mM acetic acid. Volumes shown below refer to acetic acid, not water.
What amount do you need?
Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.
Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure
Example PEG-IGF-1 Titration Schedule
Parameter
Details
Typical Dosage (SC injection)
0.3 – 8 mg (research up to 200-400 mcg)
Route
Subcutaneous (SC) or Intramuscular (IM) into targeted muscle
Frequency
Once every 3–8 days, ideally once weekly
Cycle Length
Usually 4–6 weeks on, followed by 4–6 weeks off
Half‑life
Greatly extended to 140–200 hours (6–8 days)
Reconstitution
Use sterile bacteriostatic water or 0.6% acetic acid (AA)
Reconstitution Storage
Refrigerate (2-8°C) and use within 2–7 days
Possible vial strengths:
What Is It?
PEG-IGF-1
Pegylated IGF-1 with extended half-life.
Acetic Acid (0.1%)
A dilute solution of acetic acid (typically 0.1% for most peptides, or 50 mM for IGF-1 variants) used to reconstitute peptides that are insoluble or unstable in standard bacteriostatic water. PEG-IGF-1 requires an acidic carrier to dissolve fully and remain stable — plain BAC water will not work and may damage the peptide.
How To Mix PEG-IGF-1
1
Clean
Use alcohol swabs to clean the tops of both vials.
2
Draw Acetic Acid
Draw the selected amount of 0.1% acetic acid.
3
Inject Slowly
Add the liquid slowly down the side of the vial.
4
Swirl Gently
Do not shake. Swirl gently until dissolved.
5
Store Properly
Store as directed and protect from heat and light.
Best Practices & Common Mistakes
Best Practices
Use sterile technique.
Protect from light and heat.
Store refrigerated when appropriate.
Use clean syringe-unit math before measuring.
Common Mistakes
Confusing milligrams with milliliters.
Choosing an option with awkward decimal units.
Using too little liquid for very small measurements.
Shaking the vial aggressively.
PEG-IGF-1 Storage & Handling
Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Frequently Asked Questions
Yes, the same concentration math can be used when the inputs are known: compound amount, liquid volume, and target concentration. The calculator does not decide whether IGF-1 LR3 and PEG MGF belong together; it only converts vial amount and solution volume into mg/mL or mcg/mL values for research planning
Because “cycle” usually implies personal-use timing or dosing, which a reconstitution calculator should not provide. A safer calculator FAQ can explain how separate vial strengths and liquid volumes change concentration, without giving protocols, schedules, or use instructions.
In calculator terms, “PEG IGF-1” should be treated as a label that still needs exact vial information before any math is useful. The key inputs are the measured amount of material in the vial and the final liquid volume, because those determine the working concentration.
No, the basic concentration formula does not change: amount divided by final volume. What changes is the compound identity, labeling, molecular form, and research context, so each vial should be calculated separately instead of assuming the same concentration setup applies to both.
No. A reconstitution calculator can only show concentration math, such as how much compound is present per mL after liquid is added. It should not provide injury-repair dosing, medical advice, injection guidance, or human-use protocols.
Practical takeaway: If your real goal is weight or metabolic health, the most useful next step is discussing approved treatment options with a clinician rather than relying on an unapproved compound.